Cargando…

Identification and Validation of m6A-Related lncRNA Signature as Potential Predictive Biomarkers in Breast Cancer

The metastasis and poor prognosis are still regarded as the main challenge in the clinical treatment of breast cancer (BC). Both N6-methyladenosine (m6A) modification and lncRNAs play vital roles in the carcinogenesis and evolvement of BC. Considering the unknown association of m6A and lncRNAs in BC...

Descripción completa

Detalles Bibliográficos
Autores principales:	Lv, Wenchang, Wang, Yichen, Zhao, Chongru, Tan, Yufang, Xiong, Mingchen, Yi, Yi, He, Xiao, Ren, Yuping, Wu, Yiping, Zhang, Qi
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2021
Materias:	Oncology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8555664/ https://www.ncbi.nlm.nih.gov/pubmed/34722303 http://dx.doi.org/10.3389/fonc.2021.745719

Ejemplares similares

Current Progress in Breast Implant-Associated Anaplastic Large Cell Lymphoma
por: Wang, Yichen, et al.
Publicado: (2022)

Analysis and validation of m6A regulatory network: a novel circBACH2/has-miR-944/HNRNPC axis in breast cancer progression
por: Lv, Wenchang, et al.
Publicado: (2021)

Identification of pyroptosis‐related lncRNAs for constructing a prognostic model and their correlation with immune infiltration in breast cancer
por: Lv, Wenchang, et al.
Publicado: (2021)

Current Landscape: The Mechanism and Therapeutic Impact of Obesity for Breast Cancer
por: Zhao, Chongru, et al.
Publicado: (2021)

Identification of an Aging-Related Gene Signature in Predicting Prognosis and Indicating Tumor Immune Microenvironment in Breast Cancer
por: Lv, Wenchang, et al.
Publicado: (2021)

Tumor-Derived Exosomal Non-Coding RNAs: The Emerging Mechanisms and Potential Clinical Applications in Breast Cancer
por: Yi, Yi, et al.
Publicado: (2021)

Breast Reconstruction Does Not Affect the Survival of Patients with Breast Cancer Located in the Central and Nipple Portion: A Surveillance, Epidemiology, and End Results Database Analysis
por: Xiong, Mingchen, et al.
Publicado: (2022)

Tumor-derived exosomal components: the multifaceted roles and mechanisms in breast cancer metastasis
por: Tan, Yufang, et al.
Publicado: (2021)

FTY720 Improves the Survival of Autologous Fat Grafting by Modulating Macrophages Toward M2 Polarization Via STAT3 Pathway
por: Yi, Yi, et al.
Publicado: (2021)

Circular RNAs: Their Role in the Pathogenesis and Orchestration of Breast Cancer
por: He, Xiao, et al.
Publicado: (2021)

Exosomes From Adipose-Derived Stem Cells: The Emerging Roles and Applications in Tissue Regeneration of Plastic and Cosmetic Surgery
por: Xiong, Mingchen, et al.
Publicado: (2020)

Cancer-associated fibroblasts-derived lncRNA signature as a putative biomarker in breast cancer
por: Li, Zan, et al.
Publicado: (2022)

Identification and Validation of a Prognostic lncRNA Signature for Hepatocellular Carcinoma
por: Li, Wang, et al.
Publicado: (2020)

Landscape of prognosis and immunotherapy responsiveness under tumor glycosylation-related lncRNA patterns in breast cancer
por: Lv, Wenchang, et al.
Publicado: (2022)

Transcription Factor E2F1 Knockout Promotes Mice White Adipose Tissue Browning Through Autophagy Inhibition
por: Xiong, Mingchen, et al.
Publicado: (2021)

Identification and Validation of an Autophagy-Related lncRNA Signature for Patients With Breast Cancer
por: Zhang, Ruyue, et al.
Publicado: (2021)

Cancer-associated adipocytes: emerging supporters in breast cancer
por: Zhao, Chongru, et al.
Publicado: (2020)

Deciphering the Emerging Roles of Adipocytes and Adipose-Derived Stem Cells in Fat Transplantation
por: Yi, Yi, et al.
Publicado: (2021)

Identification and Validation of a Novel Immune-Related lncRNA Signature for Bladder Cancer
por: Hua, Shan, et al.
Publicado: (2021)

LncRNA PELATON, a Ferroptosis Suppressor and Prognositic Signature for GBM
por: Fu, Haijuan, et al.
Publicado: (2022)

CCDC69 is a prognostic marker of breast cancer and correlates with tumor immune cell infiltration
por: Yi, Yi, et al.
Publicado: (2022)

Characterization of the Prognostic m6A-Related lncRNA Signature in Gastric Cancer
por: Wang, Haixu, et al.
Publicado: (2021)

Identification and Validation of a Stromal EMT Related LncRNA Signature as a Potential Marker to Predict Bladder Cancer Outcome
por: Du, YiHeng, et al.
Publicado: (2021)

Identification and Validation of an Immune-Related lncRNA Signature to Facilitate Survival Prediction in Gastric Cancer
por: Ma, Ensi, et al.
Publicado: (2021)

Identification and validation of an anoikis-related lncRNA signature to predict prognosis and immune landscape in osteosarcoma
por: Zhang, Jun-Song, et al.
Publicado: (2023)

The lncRNA epigenetics: The significance of m6A and m5C lncRNA modifications in cancer
por: Cusenza, Vincenza Ylenia, et al.
Publicado: (2023)

Integrated Analysis of a Competing Endogenous RNA Network Reveals a Prognostic lncRNA Signature in Bladder Cancer
por: Peng, Mou, et al.
Publicado: (2021)

Development and Validation of an Autophagy-Related LncRNA Prognostic Signature in Head and Neck Squamous Cell Carcinoma
por: Shen, Lin, et al.
Publicado: (2021)

Construction of an Immune-Related lncRNA Signature That Predicts Prognosis and Immune Microenvironment in Osteosarcoma Patients
por: He, Yi, et al.
Publicado: (2022)

Pyroptosis-Related LncRNA Signature Predicts Prognosis and Is Associated With Immune Infiltration in Hepatocellular Carcinoma
por: Liu, Ze-Kun, et al.
Publicado: (2022)

lncRNA PRADX is a Mesenchymal Glioblastoma Biomarker for Cellular Metabolism Targeted Therapy
por: Xu, Can, et al.
Publicado: (2022)

Pyroptosis-Related LncRNA Signatures Correlate With Lung Adenocarcinoma Prognosis
por: Huang, Hua, et al.
Publicado: (2022)

Construction of m6A-Related lncRNA Prognostic Signature Model and Immunomodulatory Effect in Glioblastoma Multiforme
por: Xie, Pan, et al.
Publicado: (2022)

Epigenetic modification mechanisms involved in keloid: current status and prospect
por: Lv, Wenchang, et al.
Publicado: (2020)

Identification and Validation of an m6A-Related LncRNA Signature to Predict Progression-Free Survival in Colorectal Cancer
por: Zhang, Yong, et al.
Publicado: (2022)

Derivation, Comprehensive Analysis, and Assay Validation of a Pyroptosis-Related lncRNA Prognostic Signature in Patients With Ovarian Cancer
por: Cao, Xueyan, et al.
Publicado: (2022)

Construction and validation of a cuproptosis-related lncRNA signature as a novel and robust prognostic model for colon adenocarcinoma
por: Xu, Miaorong, et al.
Publicado: (2022)

A Novel Matrisomal-Related LncRNA Signature Associated With Survival Outcome and Immune Evasion in Patients With Gastric Cancer
por: Yang, Yuan, et al.
Publicado: (2022)

Sonographic Features of Triple-Negative Breast Carcinomas Are Correlated With mRNA–lncRNA Signatures and Risk of Tumor Recurrence
por: Li, Jia-wei, et al.
Publicado: (2021)

Identification of LncRNA Prognostic Signature Associated With Genomic Instability in Pancreatic Adenocarcinoma
por: Zhu, Jinfeng, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_p3iorg0ulejhgdlhh52ffj1ih8